To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1083 | Bmy-25368 |
Potent long-acting H2-receptor antagonist
More description
|
|
| DCC1082 | Bmv109 |
Novel fluorescent activity-based probe (ABP), being intrinsically dark and only emitting fluorescence after reaction with the target protease, are ideally suited for imaging techniques such as small animal noninvasive fluorescence imaging and live cell fl
More description
|
|
| DCC1081 | Bmsg-sh-3 |
G-quadruplex ligand, decreasing oncogene expression
More description
|
|
| DCC1080 | Bms-986139 |
Novel pan-genotype inhibitor of HCV NS5B polymerase via binding to the primer grip site
More description
|
|
| DCC1079 | Bms-986133 |
Novel γ-secretase modulator
More description
|
|
| DCC1078 | Bms-986104 |
Novel S1P1 receptor modulator
More description
|
|
| DCC1077 | Bms-986034 |
Novel GPR119 agonist
More description
|
|
| DCC1076 | Bms-961 |
Selective RARγ agonist
More description
|
|
| DCC1075 | Bms-960 |
Novel Agonist of Sphingosine-1-Phosphate (S1P1)
More description
|
|
| DCC1074 | Bms-903452 |
Potent and selective GPR119 agonist
More description
|
|
| DCC1073 | Bms-902483 |
Potent alpha7 Nicotinic receptor partial agonist, improving cognition in preclinical rodent model
More description
|
|
| DCC1072 | Bms-883559 |
Novel inhibitor of the influenza nucleoprotein (INF-NP)
More description
|
|
| DCC1071 | Bms-870145 |
Novel potent and selective P2Y1 purinergic receptor antagonist.
More description
|
|
| DCC1070 | Bms-821095 |
Potent, Orally Bioavailable, Metabolically Stable Thumb Site 1 Inhibitor of the Hepatitis C Virus NS5B RNA-Dependent, RNA Polymerase
More description
|
|
| DCC1069 | Bms-764459 |
Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1)
More description
|
|
| DCC1068 | Bms-763534 |
Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1)
More description
|
|
| DCC1067 | Bms-698861 |
Novel Novel γ-secretase modulator, decreasing Aß1-40 and Aß1-42 and increasing Aß1-37 and Aß1-38 in rat brain modulator, decreasing Aß1-40 and Aß1-42 and increasing Aß1-37 and Aß1-38 in rat brain
More description
|
|
| DCC1066 | Bms-665053 |
Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1)
More description
|
|
| DCC1065 | Bms-585248 |
Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment
More description
|
|
| DCC1064 | Bms-566394 |
Novel, potent, exceptionally selective inhibitor of TNF-α Converting Enzyme (TACE)
More description
|
|
| DCC1063 | Bms-538305 Tartrate |
Potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor
More description
|
|
| DCC1062 | Bms-488043 |
Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment
More description
|
|
| DCC1061 | Bms-422461 |
Prodrug of the novel fluoro-substituted camptothecin analog, BMS-286309
More description
|
|
| DCC1060 | Bms-351 |
Novel Selective CYP17A1 Lyase Inhibitor
More description
|
|
| DCC1059 | Bms-341 |
Novel dissociated glucocorticoid receptor modulator
More description
|
|
| DCC1058 | Bms-286309 |
Novel fluoro-substituted camptothecin, inducing topoisomerase I-mediated DNA breaks
More description
|
|
| DCC1057 | Bms-281384 |
Highly potent and selective phosphodiesterase 5 (PDE 5) inhibitor
More description
|
|
| DCC1056 | Bms-262084 |
Potent and selective beta-lactam tryptase inhibitor, inhibiting factor XIa and producing antithrombotic efficacy with minimal bleeding time prolongation
More description
|
|
| DCC1055 | Bms-250685 |
Selective ATP hydrolase inhibitor
More description
|
|
| DCC1054 | Bms-243117 |
Potent and selective p56(lck) inhibitor
More description
|
|